author-photo

Roger Lacave

Pierre-and-Marie-Curie University

53

Papers

1324

Citations

Citation Trend

Filter By

Papers (31) Sort By

Journal Conference Others

Ceritinib ALK T1151R Resistance Mutation in Lung Cancer With Initial Response to Brigatinib

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers

2017 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (15)
Mutational profile of HPV-driven head and neck cancers according to tobacco consumption.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
NRG1 fusion in a French cohort of invasive mucinous lung adenocarcinoma

2016 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (19)
Whole exome sequencing (WES) and RNA sequencing (RNA-seq) in routine clinical practice for colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) patients (pts)

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Comparative analysis of micro-RNAs in human papillomavirus-positive versus -negative oropharyngeal cancers.

2016 Head and Neck-journal for The Sciences and Specialties of The Head and Neck
Show All
- Source
- Cite
- Save
Citations (13)
AN INTERNATIONAL INTER-LABORATORY DIGITAL PCR STUDY DEMONSTRATES HIGH REPRODUCIBILITY FOR THE MEASUREMENT OF A RARE SEQUENCE VARIANT

2016 bioRxiv
Show All
- Source
- Cite
- Save
Citations (1)
Cost-effectiveness of KRAS, EGFR and ALK testing for therapeutic decision making of advanced stage non-small cell lung cancer (NSCLC): the French IFCT-PREDICT.amm study

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
1239 Microcosting evaluation of prognostic/predictive biomarkers performed in a large French prospective cohort of non previously treated advanced NSCLC. Preliminary report of the IFCT-PREDICT.amm cohort

2015 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study

2015 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (6)